Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | East Midlands Pharmacy Collaborative |
| Main Category: | Services |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 7 May 2025 |
| Application Deadline: | 11 October 2024 |
| Contract Start Date: | 30 April 2025 |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to (6 suppliers)
| Award value: | £2,760,000 |
| Award decision date: | 29 April 2025 |
| Award status: | Active |
This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
11 October 2024
Closed
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Contract End Date: |
| 30 April 2027 |
| Contract Duration: | 2.0 years |
| Procurement ID (OCID): | ocds-b5fd17-e8653637-3725-450a-adef-4614a52dc955 |
| Notice Reference: | ee03e54b-8a5c-4058-a614-0eeb9ddb5f73-843938 |